Daiichi Sankyo has announced plans to invest approximately $1.07 billion to expand a site near Munich, Germany, to boost its work on precision cancer drugs.   Reuters reports, the investment was announced as health minister Karl Lauterbach visited the center in Pfaffenhofen, north of Daiichi’s European headquarters in Munich.   The project will create 350 jobs by 2030 and will add capacity to make cardiovascular drugs and labs to develop and produce antibody drug conjugates (ADCs).   ...